Acadian Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Acadian Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-36	Closed	-$3K	–	1600
2016 Q2	$3K	Buy	+36	New	+$3.03K	﹤0.01%	1338
2015 Q3	–	Sell	-25	Closed	-$3K	–	1490
2015 Q2	$3K	Buy	+25	New	+$2.84K	﹤0.01%	1305

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management's GWPH Position: Q3 2016 in Review

Acadian Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2016, closing a stake of 36 shares — an estimated $3K sold.

Acadian Asset Management first reported a position in GWPH in Q2 2015 and held it in 2 quarters. The position peaked at $3K in Q2 2016. 138 funds tracked by Wall St. Rank hold GWPH as of Q3 2016.

Acadian Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2016 after selling out during the quarter.
Acadian Asset Management sold 36 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2016, an estimated $3K.
Acadian Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and held it in 2 quarters.
Acadian Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3K in Q2 2016.
138 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2016.

Based on Acadian Asset Management's 13F filing for Q3 2016, filed 20 Oct 2016.